Both CCND2 and MMP9 transcripts harbor 3′-UTR recognition sites for miR-204 suggesting that miR-204 may play a tumor suppressor role in RB progression by targeting CCND2 and MMP9 [182]. The gene discussed is MMP9; the disease is retinoblastoma.